EcoDrugPlus

Activin A Receptor Like Type 1

Ensembl ID : ENSBMSG00010006622
Gene Symbol: ACVRL1
1 Cross references
358 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSBMSG00010022545
Gene Symbol: ACVR2B
1 Cross references
259 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSBMSG00010017943
Gene Symbol: ADORA2A
1 Cross references
264 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSBMSG00010015868
Gene Symbol: ADORA2B
1 Cross references
201 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSBMSG00010016862
Gene Symbol: ADA
1 Cross references
219 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSBMSG00010001276
Gene Symbol: ADRA1A
1 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSBMSG00010010374
Gene Symbol: ADRA1B
1 Cross references
265 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSBMSG00010010493
Gene Symbol: ADRA1D
1 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSBMSG00010020181
Gene Symbol: ADRA2A
1 Cross references
227 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSBMSG00010008691
Gene Symbol: ADRA2C
1 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSBMSG00010000651
Gene Symbol: ADRB2
1 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSBMSG00010016494
Gene Symbol: ADRB3
1 Cross references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).